sj-docx-1-tab-10.1177_1759720X221084848 �� Supplemental material for Infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studies

Authors :: Savarirayan, Ravi
De Bergua, Josep Maria
Arundel, Paul
McDevitt, Helen
Cormier-Daire, Valerie
Saraff, Vrinda
Skae, Mars
Delgado, Borja
Leiva-Gea, Antonio
Santos-Simarro, Fernando
Salles, Jean Pierre
Nicolino, Marc
Rossi, Massimiliano
Kannu, Peter
Bober, Michael B.
Phillips, John
Saal, Howard
Harmatz, Paul
Burren, Christine
Gotway, Garrett
Cho, Terry
Muslimova, Elena
Weng, Richard
Rogoff, Daniela
Hoover-Fong, Julie
Irving, Melita
Publication Year :: 2022
Publisher :: SAGE Journals, 2022.
Abstract: Supplemental material, sj-docx-1-tab-10.1177_1759720X221084848 for Infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studies by Ravi Savarirayan, Josep Maria De Bergua, Paul Arundel, Helen McDevitt, Valerie Cormier-Daire, Vrinda Saraff, Mars Skae, Borja Delgado, Antonio Leiva-Gea, Fernando Santos-Simarro, Jean Pierre Salles, Marc Nicolino, Massimiliano Rossi, Peter Kannu, Michael B. Bober, John Phillips, Howard Saal, Paul Harmatz, Christine Burren, Garrett Gotway, Terry Cho, Elena Muslimova, Richard Weng, Daniela Rogoff, Julie Hoover-Fong and Melita Irving in Therapeutic Advances in Musculoskeletal Disease

Subjects :: FOS: Clinical medicine
110604 Sports Medicine
FOS: Health sciences
111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
110314 Orthopaedics

Full Text Access

Tools